4D Molecular Therapeutics, Inc. 8-K

Accession 0001564590-21-034575

Filing information

CIK: 0001650648
Report date: 2021-06-18
Filing date: 2021-06-25
Form: 8-K
Primary document: fdmt-8k_20210618.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.